BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 22089003)

  • 1. The impact of uncertainties associated with MammoSite brachytherapy on the dose distribution in the breast.
    Bensaleh S; Bezak E
    J Appl Clin Med Phys; 2011 Nov; 12(4):3464. PubMed ID: 22089003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of source position uncertainties & balloon deformation in MammoSite brachytherapy on treatment effectiveness.
    Bensaleh S; Bezak E
    Australas Phys Eng Sci Med; 2010 Mar; 33(1):35-44. PubMed ID: 20300986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review of MammoSite brachytherapy: advantages, disadvantages and clinical outcomes.
    Bensaleh S; Bezak E; Borg M
    Acta Oncol; 2009; 48(4):487-94. PubMed ID: 19031175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose perturbations due to contrast medium and air in mammosite treatment: an experimental and Monte Carlo study.
    Cheng CW; Mitra R; Li XA; Das IJ
    Med Phys; 2005 Jul; 32(7):2279-87. PubMed ID: 16121583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose perturbations due to contrast medium and air in MammoSite
    Cheng CW; Mitra R; Allen Li X; Das IJ
    Med Phys; 2005 Jul; 32(7Part1):2279-2287. PubMed ID: 28493571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment volume and dose optimization of MammoSite breast brachytherapy applicator.
    Dickler A; Kirk M; Choo J; Hsi WC; Chu J; Dowlatshahi K; Francescatti D; Nguyen C
    Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):469-74. PubMed ID: 15145164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the use of HDR 60Co source with the MammoSite radiation therapy system.
    Baltas D; Lymperopoulou G; Zamboglou N
    Med Phys; 2008 Dec; 35(12):5263-8. PubMed ID: 19175085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Five-year results: the initial clinical trial of MammoSite balloon brachytherapy for partial breast irradiation in early-stage breast cancer.
    Benitez PR; Keisch ME; Vicini F; Stolier A; Scroggins T; Walker A; White J; Hedberg P; Hebert M; Arthur D; Zannis V; Quiet C; Streeter O; Silverstein M
    Am J Surg; 2007 Oct; 194(4):456-62. PubMed ID: 17826055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of organ doses for patients undergoing balloon brachytherapy of the breast with HDR 192Ir or electronic sources using monte carlo simulations in a heterogeneous human phantom.
    Mille MM; Xu XG; Rivard MJ
    Med Phys; 2010 Feb; 37(2):662-71. PubMed ID: 20229875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrast effects on dosimetry of a partial breast irradiation system.
    Kassas B; Mourtada F; Horton JL; Lane RG
    Med Phys; 2004 Jul; 31(7):1976-9. PubMed ID: 15305449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The MammoSite breast brachytherapy applicator: a review of technique and outcomes.
    Dickler A; Kirk MC; Chu J; Nguyen C
    Brachytherapy; 2005; 4(2):130-6. PubMed ID: 15893266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preliminary results and evaluation of MammoSite balloon brachytherapy for partial breast irradiation for pure ductal carcinoma in situ: a phase II clinical study.
    Benitez PR; Streeter O; Vicini F; Mehta V; Quiet C; Kuske R; Hayes MK; Arthur D; Kuerer H; Freedman G; Keisch M; Dipetrillo T; Khan D; Hudes R
    Am J Surg; 2006 Oct; 192(4):427-33. PubMed ID: 16978943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three-dimensional quantitative dose reduction analysis in MammoSite balloon by Monte Carlo calculations.
    Zhang Z; Parsai EI; Feldmeier JJ
    J Appl Clin Med Phys; 2007 Nov; 8(4):139-151. PubMed ID: 18449153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose modification factors for 192Ir high-dose-rate irradiation using Monte Carlo simulation.
    Kassas B; Mourtada F; Horton JL; Lane RG; Buchholz TA; Strom EA
    J Appl Clin Med Phys; 2006 Aug; 7(3):28-34. PubMed ID: 17533345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of breast-air and breast-lung interfaces on the dose rate at the planning target volume of a MammoSite catheter for Yb-169 and Ir-192 HDR sources.
    Cazeca MJ; Medich DC; Munro JJ
    Med Phys; 2010 Aug; 37(8):4038-45. PubMed ID: 20879565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical experience with the MammoSite radiation therapy system for brachytherapy of breast cancer: results from an international phase II trial.
    Niehoff P; Polgár C; Ostertag H; Major T; Sulyok Z; Kimmig B; Kovács G
    Radiother Oncol; 2006 Jun; 79(3):316-20. PubMed ID: 16780977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early European experience with the MammoSite radiation therapy system for partial breast brachytherapy following breast conservation operation in low-risk breast cancer.
    Niehoff P; Ballardini B; Polgár C; Major T; Hammer J; Richetti A; Kovács G
    Breast; 2006 Jun; 15(3):319-25. PubMed ID: 16765284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accelerated partial breast irradiation: a dosimetric comparison of three different techniques.
    Weed DW; Edmundson GK; Vicini FA; Chen PY; Martinez AA
    Brachytherapy; 2005; 4(2):121-9. PubMed ID: 15893265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose modification factor analysis of multilumen balloon brachytherapy applicator with Monte Carlo simulation.
    Pearson D; Williams EA
    J Appl Clin Med Phys; 2013 May; 15(3):54–62. PubMed ID: 24892326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The MammoSite breast brachytherapy device: targeted delivery of breast brachytherapy.
    Dickler A
    Future Oncol; 2005 Dec; 1(6):799-804. PubMed ID: 16556059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.